Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CSB-001 by Claris Biotherapeutics for Keratitis: Likelihood of Approval
CSB-001 is under clinical development by Claris Biotherapeutics and currently in Phase II for Keratitis. According to GlobalData, Phase II...
CSB-001 by Claris Biotherapeutics for Unspecified Ophthalmological Disorders: Likelihood of Approval
CSB-001 is under clinical development by Claris Biotherapeutics and currently in Phase I for Unspecified Ophthalmological Disorders. According to GlobalData,...
CSB-001 by Claris Biotherapeutics for Limbal Stem Cell Deficiency (LSCD): Likelihood of Approval
CSB-001 is under clinical development by Claris Biotherapeutics and currently in Phase I for Limbal Stem Cell Deficiency (LSCD). According...